Stifel Financial Corp Astrazeneca PLC Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Stifel Financial Corp holds 1,265,418 shares of AZN stock, worth $98.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,265,418

Previous 1,126,711 12.31%

Holding current value

$98.2 Million

Previous $76.3 Million 29.29%

% of portfolio

0.11%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $9.27 Million - $11.2 Million	138,707 Added 12.31%	1,265,418 $98.7 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $9.25 Million - $10.5 Million	-151,588 Reduced 11.86%	1,126,711 $76.3 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $4.83 Million - $5.41 Million	-78,089 Reduced 5.76%	1,278,299 $86.1 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $696,683 - $770,273	10,743 Added 0.8%	1,356,388 $91.9 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1.45 Million - $1.57 Million	-20,763 Reduced 1.52%	1,345,645 $96.3 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $11 Million - $12.4 Million	173,412 Added 14.54%	1,366,408 $94.8 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $1.63 Million - $2.12 Million	30,077 Added 2.59%	1,192,996 $80.9 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $12.2 Million - $31.2 Million	230,107 Added 24.67%	1,162,919 $63.8 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $34.3 Million - $41.2 Million	578,473 Added 163.25%	932,812 $61.6 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $205,662 - $247,739	-3,691 Reduced 1.03%	354,339 $23.5 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $194,580 - $229,915	3,602 Added 1.02%	358,030 $20.9 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $2.29 Million - $2.5 Million	41,131 Added 13.13%	354,428 $21.3 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $539,544 - $670,585	11,143 Added 3.69%	313,297 $18.8 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $1.92 Million - $2.21 Million	-40,641 Reduced 11.86%	302,154 $15 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $26.5 Million - $31.7 Million	-546,863 Reduced 61.47%	342,795 $17.1 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $572,943 - $659,635	10,796 Added 1.23%	889,658 $48.8 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $21 Million - $26.9 Million	486,704 Added 124.11%	878,862 $46.5 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $139,936 - $190,074	3,703 Added 0.95%	392,158 $17.5 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $3.87 Million - $4.6 Million	91,190 Added 30.68%	388,455 $19.4 Million
Q3 2019 Nov 19, 2019	SELL	$40.12 - $45.47 $15,486 - $17,551	-386 Reduced 0.13%	297,265 $13.2 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $1.41 Million - $1.59 Million	-35,054 Reduced 10.54%	297,651 $13.2 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $3.71 Million - $4.14 Million	99,393 Added 42.6%	332,705 $13.7 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $4.59 Million - $5.56 Million	-129,222 Reduced 35.64%	233,312 $9.43 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $848,996 - $955,639	-23,033 Reduced 5.97%	362,534 $13.8 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $1.27 Million - $1.45 Million	-36,523 Reduced 8.65%	385,567 $15.3 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $1.5 Million - $1.61 Million	-43,554 Reduced 9.35%	422,090 $14.8 Million
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $435,995 - $484,395	13,224 Added 2.92%	465,644 $16.3 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $1.5 Million - $1.62 Million	46,601 Added 11.48%	452,420 $15.7 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $11.8 Million - $13.8 Million	405,819	405,819 $0

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Astrazeneca PLC Transaction History